Delivery Order SPE2DR25D1109-SPE2DR26FFJ0X
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Durolane 60 mg/3 ml syringes with a ceiling value of $3,329.64 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of November 18, 2025. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Durolane 60 mg/3 ml syringes with a ceiling value of $26,472.85. This firm fixed-price delivery order, with an ultimate completion date of December 12, 2025, represents a continuation of the company's role as a critical pharmaceutical supplier to the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a major healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,565.96 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on December 5, 2025, with a completion date of December 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's corporate headquarters location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $10,514.15. This non-competitive, firm fixed-price delivery order is set to be completed by December 11, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $1,679.80 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Durolane 60 mg/3 ml syringes. This competitively awarded, firm fixed-price delivery order is expected to be completed by December 4, 2025, with fulfillment occurring at the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Durolane 60 mg/3 ml syringes at a ceiling value of $1,275.20. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's location...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.67 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Durolane 60 mg/3 ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this requirement as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,495.41 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on December 11, 2025, with completion targeted for December 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's significantly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,736.84 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFJ0XDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $6,257.14 on December 16, 2025, for the supply of Durolane 60 mg/3 mL syringes. This is a firm fixed-price delivery order under a competitive procurement with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical contract enables AmerisourceBergen to supply pharmaceutical products to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key provider within the federal healthcare procurement landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 12/15/25 |